|Articles|August 5, 2016
Pharma Company Selects OmniComm Platform
OmniComm Systems announces the selection of its Trial One platform by a pharmaceutical company to automate its Phase I and BA/BA clinic.
Advertisement
OmniComm Systems announces the selection of its Trial One platform by a pharmaceutical company to automate its Phase I and BA/BE clinic. The company aims to standardize its processes, improve business intelligence, ensure compliance, and transform its overall business within its early phase research.
Read the full release here
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- eClinical Technology: Misconceptions, Challenges, and Opportunities
September 9th 2025
- How Sponsors Can Modernize Tools to Support Physicians
September 9th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AstraZeneca’s Tagrisso Shows Landmark Overall Survival Benefit in Non-Small Cell Lung Cancer
2
Phase III EMPOWER-Lung 3 Trial Confirms Five-Year Survival Benefit With Libtayo Plus Chemotherapy in NSCLC
3
Pfizer, BioNTech’s Comirnaty Shows Strong Immune Response in Phase III Trial for COVID-19
4
Investigational OX40-Targetting T-Cell Therapy Shows Durable Efficacy Treating Atopic Dermatitis in Phase III Trial
5